| Structure |
Intermediate Name |
CAS No |
API/ END USE |
 |
Ethyl 3-(3-amino-4-(methyl amino)-N-(pyridin-2-yl) benzamido) propanoate/ DGT-3 |
212322-56-0 |
Dabigatran |
 |
2-(4-Cyanophenylamino) Acetic Acid/ DGT-4 |
42288-26-6 |
Dabigatran |
 |
Ethyl-3-[[[2-[[(4-cyanophenyl) amino] methyl]-1methyl-1H-benzimidazol-5-yl] carbonyl] pyridine-2-ylamino] propionate/DGT5 |
211915-84-3 |
Dabigatran |
 |
Ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride//DGT6 |
211914-50-0 |
Dabigatran |
 |
2,3,4,6-tetrakis-o-trimethylsilyl-d-gluconolactone/ DGL1 |
32384-65-9 |
Dapagliflozin/
Empa Canagliflozin
|
 |
4-Chloro Benzhydryl Piperazine/ CBP3 |
303-26-4 |
Cetirizine / Buclizine/ Meclizine/Hydroxyzine/ Etodroxizine |
 |
Formamidine acetate salt / ACF |
3473-63-0 |
Itraconazole/
Ibrutinib/Tofacitinib
|
 |
5-chloro-4-amino-2,1,3-benzothiadiazole / ABT3 |
30536-19-7 |
Tizanidine |
 |
N N’ Di isopropyl carbodiimide// NNDIC |
693-13-0 |
Tirzepatide// Liraglutide/Semaglutide |
 |
8-Chloro-5,10-dihydro-11H-dibenzo[b,e][1,4]-diazepin-11-one,
/COD-3 |
50892-62-1 |
Clozapine |
 |
2-(2-Aminothiazol-4-yl) acetic acid /
AAA-2 |
29676-71-9 |
Mirabegron |
 |
2-(4-nitrophenyl)ethanamine hydrochloride /NPA-2 |
29968-78-3 |
Mirabegron
|
 |
(R)-2-Hydroxy-N-(4-nitrophenethyl)-2-phenylacetamide/MGN-1 |
521284-19-5 |
Mirabegron |
 |
(R)-2-(4-nitrophenethylamino)-1- Phenylethanol MGN 2 |
223673-34-5 |
Mirabegron
|
 |
(R)-2-(4-nitrophenethylamino)-1-phenylethanol hydrochloride/ MGN 2HCL |
521284-21-9 |
Mirabegron
|
 |
(R)-2-((4-Aminophenethyl)amino)-1-phenylethanol//MGN3Base |
391901-45-4 |
Mirabegron
|
 |
(R)-2-(4-aminophenethylamino)-1-Phenylethanol hydrochloride/ MGN 3// N-1 |
521284-22-0 |
Mirabegron
|
 |
Methyl 5-tert-butyl-2-hydroxy benzoate//SAS-2 |
52888-72-9 |
Deutivacaftor |
 |
2-Butyl-1,3-diazaspiro[4.4]non-1-en-4-oneHydrochloride/Spiro Compound/TBI-3 |
151257-01-1 |
Irbesartan |
 |
(betaR,gammaR)-gamma-Ethyl-3-methoxy-N,N,beta-trimethylbenzenepropanamine hydrochloride(N-1) |
175591-17-0 |
Tapentadol |
 |
(2-ethoxyethyl 4-methylbenzenesulfonate)// EPB-1 |
17178-11-9 |
Bilastine |
 |
2-(Piperidin-4 yl)-1H- Benzo[d]imidazole//EPB2 |
38385-95-4 |
Bilastine |
 |
1-(2-Ethoxyethyl)-2-(piperidin-4-yl)-1H-benzo[d]imidazole hydrochloride//EPB4 |
1841081-72-8 |
Bilastine |
 |
Methyl 2-(4-(2-chloroethyl) phenyl)-2-Methyl propanoate//CPM-3 |
1181267-33-3 |
Bilastine |
 |
N,N-Dimethylamino propiophenone hydrochloride /AMT1 |
879-72-1 |
Fluoxetine |
 |
N,N-Dimethyl-3-phenyl-3-chloropropylamine hydrochloride/ AMT2 |
1011-59-2 |
Atomoxetine |
 |
N,N-dimethyl-3-phenyl-3-(O-tolyloxy)propan-1-amine oxalate/ AMT3 |
107688-86-8 |
Atomoxetine |
 |
tert-butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate |
571188-59-5 |
Ribociclib |
 |
1-(4-Morpholinophenyl)guanidine//MAN-3 |
247234-41-9 |
Momelotinib |
 |
4-((tert-butoxycarbonyl)amino)piperidine-4-carboxylic acid//CPS- |
252720-31-3 |
Capivasertib |
 |
1-(Cyclopropylcarbonyl) piperazine hydrochloride/CPP |
1021298-67-8 |
Olaparib |
 |
Dimethyl (3-oxo-1,3-dihydroisobenzofuran-1-yl)phosphonate/OLP1 |
61260-15-9 |
Olaparib |
 |
4-(Piperidin-4yl) morpholine hydrochloride /PPD2Hcl |
550370-31-5 |
Alectinib |
 |
4-(Piperidin-4yl) morpholine//PPD2 |
53617-35-9 |
Alectinib |
 |
2-Bromo-4-Nitro Imidazole/ BNI-2 |
65902-59-2 |
Delamanid/Pretomanid |
 |
(R)-2-(tert-butoxycarbonylamino)-2-phenylethyl methanesulfonate//IEL |
102089-75-8 |
Elagolix |
 |
9,10-dimethoxy-2-(2,4,6-trimethylanilino)-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one//ETS4 |
76536-66-8 |
Ensifentrine |
 |
N-Methoxy-N-methylacetamide) NMMA, |
78191-00-1 |
Pyridine Derivatives |
 |
2-(Chloromethyl)-4-methylquinazoline/ CLM-1 |
109113-72-6 |
Linagliptin/ Trelagliptin/ Alogliptin
|
 |
8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine BMP-2 |
666816-98-4 |
Linagliptin/ Trelagliptin/ Alogliptin
|
 |
1,4,7-Trimethyl-1,4,7-Triazacyclononane/ TTC2
(Stabilised with sodium bi carbonate) |
96556-05-7 |
Speciality chemical used in tanning/ detergents and as additive |
 |
(-)-4-Chlorobenzhydrylamine/LCH2 |
163837-57-8 |
Levocetirizine |
 |
N,N-bis(2-Chloroethyl)-4-MethylbenzeneSulfonamide/CMS |
42137-88-2 |
Levocetirizine |
| Under Development |
 |
(R)- N-methyl-3-phenyl-3-(O-tolyloxy)propan-1-amine (s)- (+)- Mandelate //(R)-tomoxetine (S)-(+)- mandelic acid salt /RTM-4 |
83113-55-7 |
Atomoxetine |
 |
Ethyl 3-amino-1H-pyrazole 4-carboxylate //EPC |
6994-25-8 |
Allopurinol |
 |
2,4-Dichloro-7h-Pyrrolo2,3-Dpyrimidine |
90123-66-4 |
Tofacitinib |
 |
4-Amino-2,6-dichlorophenol / DNP-1 |
5930-28-9 |
Resmetirom |
 |
6-(4-amino-2,6-dichlorophenoxy)-4-isopropylpyridazin-3(2H)-one// RCM-4 |
920509-28-0 |
Resmetirom |
 |
(S)-tert-butyl (1-aMino-3-(4-iodophenyl)-1-oxopropan-2-yl)carbamate//BCB3 |
868694-44-4 |
Brensocatib |
 |
3-(Hexyloxy)-4-(pyridin-3-yl)-1,2,5-thiadiazole |
131987-69-4 |
Xanomeline |
 |
5-Methyl-1,3,4-oxadiazole-2-carboxylic acid potassium salt.// PMC-3 |
888504-28-7 |
Raltegravir |
 |
1-((iso cyano methyl)sulfonyl)-4-methylbenzene// TosMIC |
36635-61-7 |
Bempedoic Acid |
 |
3-Aminopiperidine-2,6-dione hydrochloride,/DPA3 |
24666-56-6 |
Lenalidomide |
 |
Methyl-2-bromomethyl-3-nitrobenzoate/NBM2 |
98475-07-1 |
Lenalidomide |
 |
4-Bromo-1-chloro-2-[(4-ethoxyphenyl)methyl]benzene//DGP2 |
461432-23-5 |
Dapagliflozin |
 |
4-Morpholineacetic acid hydrochloride/CAR |
89531-58-8 |
Carfilzomib |
 |
6-Chloro-3-(1-Methylethyl)-2,4-(1h,3h)-Pyrimidinedione |
887581-47-7 |
Mavacamten |
 |
1-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione |
69998-14-7 |
Mavacamten |
 |
(S)-3-((2R,5S)-5-(4-Fluorophenyl)-2-((S)-((4-fluorophenyl)amino)(4-((trimethylsilyl)oxy)phenyl)methyl)-5-((trimethylsilyl)oxy)pentanoyl)-4-phenyloxazolidin-2-one |
272778-12-8 |
Ezetimibe |
 |
4-Octylphenyl Ethanol//FNG2A |
162358-05-6 |
Fingolimod |
 |
3-(3,5-dimethyl-1H-pyrazol-4-yl)propan-1-ol |
1779428-05-5 |
Acoramidis |
 |
4-(3-bromopropyl)-3,5-dimethyl-1H-pyrazole |
2167368-32-1 |
Acoramidis |
 |
3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-6-carboxylic acid |
134997-87-8 |
Balcinaranone |
 |
N-Boc-Piperidine-4-carboxylic acid methyl ester |
124443-68-1 |
Muvalaplin |
 |
1-tert-butyl 4-methyl 4-(3-bromobenzyl)piperidine-1,4-dicarboxylate |
3086955-18-9 |
Muvalaplin |
 |
4-[(3-bromophenyl)methyl]-1,4-Piperidinedicarboxylic acid 1-(1,1-dimethylethyl)ester |
1187172-25-3 |
Muvalaplin |